-
2020 Global Survey from ISAPS Sees Significant Changes in Aesthetic Procedures During Pandemic
prnasia
December 29, 2021
The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures today, which showcased the impact of the COVID-19 pandemic...
-
Health ministry approves Corbevax, Covovax and Molnupiravir for restricted use in emergency situation
ExpressPharma
December 29, 2021
The government yesterday announced that it has approved emergency use of two more COVID-19 vaccines and anti-viral drug Molnupiravir.
-
Intrivo launches 2Gather, a groundbreaking test+tech COVID-19 solution for individuals and businesses to ensure that events and meetings are held safely
prnewswire
December 29, 2021
Intrivo, a U.S.-based health-tech leader, announced today the launch of 2Gather, a new service that makes it easy for individuals and businesses to provide Intrivo's market-leading On/Go? rapid COVID-19 self-tests...
-
DoctorOnCall Offers Free Medical Assistance To Flood Victims
prnasia
December 29, 2021
Amidst Malaysia's worst flash flooding following heavy rains over the weekend that displaced tens of thousands of people, Malaysia's first and largest digital health platform, DoctorOnCall, has announced a flood relief medical assistance initiative.
-
Chinese mainland reports 182 locally transmitted COVID-19 cases
NMPA/Xinhua
December 29, 2021
The Chinese mainland on Monday reported 182 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Dec 28.
-
ChemRar’s Avifavir demonstrates effectiveness against SARS-CoV-2 variants
Pharmaceutical-Technology
December 29, 2021
Russia-based ChemRar Group has reported that its drug, Avifavir (favipiravir), demonstrated effectiveness against several SARS-CoV-2 variants, including Delta and Omicron.
-
FDA Says Rapid At-Home COVID-19 Tests Not as Sensitive to Omicron
drugs
December 29, 2021
Early research suggests that some rapid COVID-19 tests may be less able to detect the omicron variant, the U.S. Food and Drug Administration said Tuesday.
-
CDC Lowers Estimate of Omicron Prevalence in the United States
drugs
December 29, 2021
In an update that illustrates just how challenging it is to track the spread of a fast-moving virus, the U.S. Centers for Disease Control and Prevention on Tuesday lowered its estimate of how prevalent the omicron variant is in the United States.
-
Kintor Pharma Provides Update on One of its Three Multi-Regional Phase 3 Trials of Proxalutamide for COVID-19
prnasia
December 28, 2021
Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today provided an update on its multi-regional study...
-
ChemRar Group announces the Russian Avifavir? drug is effective against variants of COVID-19, including Delta and Omicron
prnasia
December 28, 2021
ChemRar Group announces the Russian Avifavir? (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects the highly conservative...